Related Experiment Videos
[Target blood pressure values from the cardiologic viewpoint]
1Klinischen Abteilung für Kardiologie, Medizinischen Universitätsklinik Graz. we.klein@kfunigraz.ac.at
Insights
Lowering diastolic blood pressure below 90 mm Hg benefits patients, even with ischemic heart disease. Aggressive blood pressure lowering is indicated for high-risk individuals to reduce cardiovascular events.
Area of Science:
- Cardiology
- Hypertension Management
- Preventive Cardiology
Context:
- Recent hypertension trials demonstrate benefits of lowering diastolic blood pressure (DBP) below 90 mm Hg.
- This finding prompts re-evaluation of target blood pressure goals in hypertension treatment.
- Ischemic heart disease does not preclude further benefit from DBP reduction.
Purpose:
- To discuss a new definition for target blood pressure in hypertension management.
- To emphasize the role of cardiological risk stratification in treatment decisions.
- To guide pharmacological blood pressure lowering strategies based on patient risk.
Summary:
- Cardiological assessment requires calculating total cardiovascular risk using a coronary risk profile.
- Risk stratification is crucial for determining appropriate pharmacological treatment and target blood pressure.
- Higher patient risk necessitates more aggressive blood pressure lowering interventions.
Impact:
- Informs clinical guidelines for hypertension management.
- Promotes personalized treatment strategies based on individual cardiovascular risk.
- Aims to improve patient outcomes by optimizing blood pressure control.
Abstract:
Recent large intervention trials in hypertension have shown that diastolic blood pressure--even in the presence of ischemic heart disease--can be reduced below 90 mm Hg with further benefit for the patient. This has lead to discussions about a new definition of target blood pressure in hypertension treatment. From a cardiological point of view, the total cardiovascular risk of the patient has to be calculated according to a coronary risk profile. This risk stratification of the patient helps to make a decision about pharmacological treatment of blood pressure and target blood pressure. The higher the risk of the individual patient, the more aggressive blood pressure lowering is indicated.